Company China Health Resource, Inc.

Equities

CHRI

US16942M2070

Pharmaceuticals

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for China Health Resource, Inc. -.--% -.--%

Business Summary

China Health Resource, Inc. is engaged in the production, manufacturing and distribution in China of herbal pharmaceuticals based on traditional Chinese medicine, which it refers to as Traditional Chinese Medicine (TCM). The Company's subsidiary Suining Shi Yinfa Bai Zhi Chan Ye You Xian Gong Si (Yinfa) is a Chinese pharmaceutical company focused on producing, processing and commercializing TCM products to pharmaceutical manufacturers and wholesale markets. The Company's products include Dahurian Angelica Root (DAR), which is a herb employed as an ingredient in food, medicine and cosmetics for the treatment of pain, swelling and pustule. Raw-DAR in both its original root form and processed form (both sliced and powder) is one of Yinfa's major products, which is sold to pharmaceutical manufacturers (80%) or wholesalers (20%). The Company's DAR-related product includes Yisheng Capsule and is sold to regional distributors throughout China.

Managers

Managers TitleAgeSince
Director of Finance/CFO 53 29/10/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 227,435,953 154,788,894 ( 68.06 %) 0 68.06 %

Company contact information

China Health Resource, Inc.

343 Sui Zhou Zhong Road

629000, Suining

+

http://www.chriglobal.com
address China Health Resource, Inc.(CHRI)
  1. Stock Market
  2. Equities
  3. CHRI Stock
  4. Company China Health Resource, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW